-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
ADC Therapeutics SA quarterly/annual Depreciation history and growth rate from Q1 2023 to Q3 2024.
- ADC Therapeutics SA Depreciation for the quarter ending September 30, 2024 was $336K, a 6.33% increase year-over-year.
- ADC Therapeutics SA Depreciation for the twelve months ending September 30, 2024 was $1.33M.
- ADC Therapeutics SA annual Depreciation for 2023 was $1.19M, a 12% increase from 2022.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)